Genomic strategies for diabetic nephropathy

Katalin Susztak, Kumar Sharma, Mario Schiffer, Peter McCue, Emilio Ciccone, Erwin P. Böttinger

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Insight into the molecular mechanisms that underlie the origin and progression of diabetic nephropathy remains limited in part because conventional research tools have restricted investigators to focus on single genes or isolated pathways. Microarray technologies provide opportunities for evaluating genetic factors and environmental effects at a genomic scale during the pathogenesis of diabetic nephropathy. Despite the enormous power of the microarray technology, there are several pitfalls that need to be considered. This article discusses conceptual, practical, statistical, and logistical considerations for the use of microarrays in studies of experimental and human diabetic renal disease. New knowledge in this field will facilitate new approaches for molecular diagnosis and drug discovery.

Original languageEnglish (US)
JournalJournal of the American Society of Nephrology
Volume14
Issue numberSUPPL. 3
StatePublished - Aug 1 2003
Externally publishedYes

Fingerprint

Diabetic Nephropathies
Technology
Drug Discovery
Research Personnel
Kidney
Research
Genes

ASJC Scopus subject areas

  • Nephrology

Cite this

Susztak, K., Sharma, K., Schiffer, M., McCue, P., Ciccone, E., & Böttinger, E. P. (2003). Genomic strategies for diabetic nephropathy. Journal of the American Society of Nephrology, 14(SUPPL. 3).

Genomic strategies for diabetic nephropathy. / Susztak, Katalin; Sharma, Kumar; Schiffer, Mario; McCue, Peter; Ciccone, Emilio; Böttinger, Erwin P.

In: Journal of the American Society of Nephrology, Vol. 14, No. SUPPL. 3, 01.08.2003.

Research output: Contribution to journalArticle

Susztak, K, Sharma, K, Schiffer, M, McCue, P, Ciccone, E & Böttinger, EP 2003, 'Genomic strategies for diabetic nephropathy', Journal of the American Society of Nephrology, vol. 14, no. SUPPL. 3.
Susztak K, Sharma K, Schiffer M, McCue P, Ciccone E, Böttinger EP. Genomic strategies for diabetic nephropathy. Journal of the American Society of Nephrology. 2003 Aug 1;14(SUPPL. 3).
Susztak, Katalin ; Sharma, Kumar ; Schiffer, Mario ; McCue, Peter ; Ciccone, Emilio ; Böttinger, Erwin P. / Genomic strategies for diabetic nephropathy. In: Journal of the American Society of Nephrology. 2003 ; Vol. 14, No. SUPPL. 3.
@article{2555851153fa4ce39508cf0fc3aaa153,
title = "Genomic strategies for diabetic nephropathy",
abstract = "Insight into the molecular mechanisms that underlie the origin and progression of diabetic nephropathy remains limited in part because conventional research tools have restricted investigators to focus on single genes or isolated pathways. Microarray technologies provide opportunities for evaluating genetic factors and environmental effects at a genomic scale during the pathogenesis of diabetic nephropathy. Despite the enormous power of the microarray technology, there are several pitfalls that need to be considered. This article discusses conceptual, practical, statistical, and logistical considerations for the use of microarrays in studies of experimental and human diabetic renal disease. New knowledge in this field will facilitate new approaches for molecular diagnosis and drug discovery.",
author = "Katalin Susztak and Kumar Sharma and Mario Schiffer and Peter McCue and Emilio Ciccone and B{\"o}ttinger, {Erwin P.}",
year = "2003",
month = "8",
day = "1",
language = "English (US)",
volume = "14",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "SUPPL. 3",

}

TY - JOUR

T1 - Genomic strategies for diabetic nephropathy

AU - Susztak, Katalin

AU - Sharma, Kumar

AU - Schiffer, Mario

AU - McCue, Peter

AU - Ciccone, Emilio

AU - Böttinger, Erwin P.

PY - 2003/8/1

Y1 - 2003/8/1

N2 - Insight into the molecular mechanisms that underlie the origin and progression of diabetic nephropathy remains limited in part because conventional research tools have restricted investigators to focus on single genes or isolated pathways. Microarray technologies provide opportunities for evaluating genetic factors and environmental effects at a genomic scale during the pathogenesis of diabetic nephropathy. Despite the enormous power of the microarray technology, there are several pitfalls that need to be considered. This article discusses conceptual, practical, statistical, and logistical considerations for the use of microarrays in studies of experimental and human diabetic renal disease. New knowledge in this field will facilitate new approaches for molecular diagnosis and drug discovery.

AB - Insight into the molecular mechanisms that underlie the origin and progression of diabetic nephropathy remains limited in part because conventional research tools have restricted investigators to focus on single genes or isolated pathways. Microarray technologies provide opportunities for evaluating genetic factors and environmental effects at a genomic scale during the pathogenesis of diabetic nephropathy. Despite the enormous power of the microarray technology, there are several pitfalls that need to be considered. This article discusses conceptual, practical, statistical, and logistical considerations for the use of microarrays in studies of experimental and human diabetic renal disease. New knowledge in this field will facilitate new approaches for molecular diagnosis and drug discovery.

UR - http://www.scopus.com/inward/record.url?scp=0042867398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042867398&partnerID=8YFLogxK

M3 - Article

VL - 14

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - SUPPL. 3

ER -